Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival-Reference-Cited by-同舟云学术

Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival

Published:2018-07-10 Issue:1 Volume:172 Page:123-132
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Saha Ashirbani^ORCID,Harowicz Michael R.,Cain Elizabeth Hope,Hall Allison H.,Hwang Eun-Sil Shelley,Marks Jeffrey R.,Marcom Paul Kelly,Mazurowski Maciej A.

Funder

National Institutes of Health

North Carolina Biotechnology Center

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-4879-7/fulltext.html

Reference37 articles.

1. Martelotto LG, Ng CKY, Piscuoglio S, Weigelt B, Reis-Filho JS (2014) Breast cancer intra-tumor heterogeneity. Breast Cancer Res 16(3):210

2. Hunter K (2015) The role of individual inheritance in tumor progression and metastasis. J Mol Med 93(7):719–725

3. Davnall F, Yip CSP, Ljungqvist G et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3(6):573–589

4. Bedard PL, Hansen AR, Ratain MJ, Siu LL (2013) Tumour heterogeneity in the clinic. Nature 501(7467):355–364

5. Henderson IC, Patek AJ (1998) The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res Treat 52(1):261–288

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance;European Journal of Cancer;2024-01

2. Tumor Heterogeneity of Breast Cancer Assessed with Computed Tomography Texture Analysis: Association with Disease-Free Survival and Clinicopathological Prognostic Factor;Diagnostics;2023-11-29

3. A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer;Cancer Research;2023-05-03

4. Tumor heterogeneity and the dilemma of antioxidant therapies in cancer;Annals of Translational Medicine;2022-10

5. The breast cancer pro-metastatic phenotype requires concomitant hyper-activation of ECM remodeling and dsRNA-IFN1 signaling in rare clone cells;2022-07-16